Pacer Advisors
SGMO

Pacer Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Pacer Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,754
Closed -$85K – 1541
2021
Q1 		$85K Sell
6,754
-1,740
-20% -$23.4K ﹤0.01% 1311
2020
Q4 		$133K Buy
8,494
+594
+8% +$6.96K ﹤0.01% 1314
2020
Q3 		$75K Buy
+7,900
New +$85.4K ﹤0.01% 1285
2018
Q4 		– Sell
-16,455
Closed -$279K – 958
2018
Q3 		$279K Buy
+16,455
New +$250K 0.01% 963
2018
Q1 		– Sell
-1,850
Closed -$30K – 1120
2017
Q4 		$30K Buy
+1,850
New +$27.5K ﹤0.01% 1066

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pacer Advisors's SGMO Position: Q2 2021 in Review

Pacer Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2021, closing a stake of 6,754 shares — an estimated $85K sold.

Pacer Advisors first reported a position in SGMO in Q4 2017 and held it in 5 quarters. The position peaked at $279K in Q3 2018. 197 funds tracked by Wall St. Rank hold SGMO as of Q2 2021.

  • Pacer Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2021 after selling out during the quarter.
  • Pacer Advisors sold 6,754 SANGAMO THERAPEUTICS INC shares in Q2 2021, an estimated $85K.
  • Pacer Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q4 2017 and held it in 5 quarters.
  • Pacer Advisors's SANGAMO THERAPEUTICS INC position peaked at $279K in Q3 2018.
  • 197 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2021.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.